Minocycline inhibited NLRP3 inflammatory bodies’ activation and associated inflammatory responses in mouse models, significantly improving brain injury induced by cerebral ischemia-reperfusion (Lu et al., 2016). This evidence concerns the gene NLRP3 and brain ischemia.